Screen Quest™ Fluorimetric Neutrophil Elastase Inhibitor Screening Kit
Price | |
Catalog Number | |
Unit Size | |
Quantity |
Telephone | 1-800-990-8053 |
Fax | 1-800-609-2943 |
sales@aatbio.com | |
International | See distributors |
Bulk request | Inquire |
Custom size | Inquire |
Shipping | Standard overnight for United States, inquire for international |
H-phrase | H303, H313, H333 |
Hazard symbol | XN |
Intended use | Research Use Only (RUO) |
R-phrase | R20, R21, R22 |
UNSPSC | 12352200 |
Overview | ![]() ![]() |
Platform
Fluorescence microplate reader
Excitation | 360 nm |
Emission | 470 nm |
Cutoff | 430 nm |
Recommended plate | Solid black |
Components
Example protocol
AT A GLANCE
Prepare the NE enzyme solution (40 μL/well).
Prepare the NE inhibitor serial dilution, and add 10 μL/well.
Incubate the NE enzyme with inhibitor for 5-10 minutes at 37 °C.
Add 50 µL of the NE working solution.
Incubate at room temperature for 10-30 minutes.
Monitor fluorescence intensity at Ex/Em = 360/470 nm, Cutoff = 430 nm.
Thaw all the kit components at room temperature before starting the experiment.
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles
Add 50 µL of the NE Assay Buffer (Component D) to the vial of NE Enzyme (Component B) to make a 100 µg/mL NE Enzyme stock solution. Mix well by pipetting, aliquot, and store at -80 °C.
Note: Must be used within 1 week of reconstitution. Avoid freeze/thaw cycles.
PREPARATION OF STANDARD SOLUTIONS
https://www.aatbio.com/tools/serial-dilution/11802
PREPARATION OF WORKING SOLUTION
Take 5 μL of the 100 μg/mL NE Enzyme stock solution and add it to 495 μL of NE Assay Buffer (Component D) to create a 1 μg/mL NE Enzyme solution.
Note: The concentration of the NE Enzyme solution needs to be optimized when using a different inhibitor.
Add 25 µL of NE Substrate (100X) (Component A) to 5 mL of NE Assay Buffer (Component D), and mix well.
Note: Prepare the NE working solution fresh before each experiment, and protect it from light.
Note: A 5 mL solution is sufficient for 100 tests. Adjust the amount of NE working solution proportionally to match the number of tests you need.
SAMPLE EXPERIMENTAL PROTOCOL
Table 1. Layout of NE inhibitor serial dilution and test samples in a 96-well solid black microplate. (STD = NE Inhibitor Standards (STD1-STD7, 1.25-80 µM), BL= Blank Control, TS = Test Samples.)
Positive Control | Positive Control | TS | TS |
STD 1 | STD 1 | ... | ... |
STD 2 | STD 2 | ... | ... |
STD 3 | STD 3 | BL | BL |
STD 4 | STD 4 | ||
STD 5 | STD 5 | ||
STD 6 | STD 6 | ||
STD 7 | STD 7 |
Table 2. Reagent composition for each well.
Well | Volume (Total 50 µL) |
STD 1-STD 7 | 40 µL NE Enzyme Solution + 10 µL NE Inhibitor Serial Dilution |
BL | 40 µL NE Enzyme Solution + 10 µL NE Assay Buffer |
GGT Positive Control | 50 µL NE Assay Buffer |
TS | 40 µL NE Enzyme Solution + 10 µL of Inhibitor Test Sample |
Prepare NE Inhibitor standards (STD1-7), blank controls (BL), positive control, and test samples (TS) as outlined in Tables 1 and 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.
Incubate the NE enzyme with inhibitor for 5-10 minutes at 37 ⁰C.
Add 50 µL of NE Substrate Working Solution to each well containing the NE Inhibitor standards (STD1-STD7), blank control, positive control, and test samples. For a 384-well plate, add 25 µL of GGT Working Solution to each well instead.
Incubate for 10-30 minutes at 37 °C, protected from light.
Monitor the fluorescence intensity with a fluorescence microplate reader at Ex/Em = 360/470 nm (Cutoff = 430 nm).
Images
References
Authors: Lulla, Amriti R and Akli, Said and Karakas, Cansu and Caruso, Joseph A and Warma, Lucas D and Fowlkes, Natalie W and Rao, Xiayu and Wang, Jing and Hunt, Kelly K and Watowich, Stephanie S and Keyomarsi, Khandan
Journal: Molecular cancer therapeutics (2024): 492-506
Authors: Ocampo-Gallego, Jhonnatan Styver and Pedroza-Escobar, David and Caicedo-Ortega, Ana Ruth and Berumen-Murra, María Teresa and Novelo-Aguirre, Ana Lucía and de Sotelo-León, Rebeca Denis and Delgadillo-Guzmán, Dealmy
Journal: Fundamental & clinical pharmacology (2024): 13-32
Authors: Wang, Lihong and Zhou, Zhoujunhao and Xu, Xinming and Li, Yue and Zhang, Rui and Yu, Zhiyan and Huang, Xinmei and Zang, Shufei and Sun, Tiange
Journal: Reproductive biology and endocrinology : RB&E (2024): 2
Authors: Zheng, Shuo and Bulut, Gamze B and Kummarapurugu, Apparao B and Ma, Jonathan and Voynow, Judith A
Journal: International journal of molecular sciences (2024)
Authors: Wan, Quan
Journal: Chemical biology & drug design (2024): e14406
Authors: Jia, Wangqiang and Mao, Yudong and Luo, Qianwen and Wu, Jiang and Guan, Quanlin
Journal: Discover oncology (2024): 167
Authors: Sun, Jia-Kui and Li, Jing-Jing and Deng, Yi-Hang and Yin, Xiang and Huangfu, Xiao-Tian and Ye, Zi-Yu and Zhou, Xue-Hui and Chen, Yong-Ming and Yuan, Shou-Tao and Wang, Xiang
Journal: Clinical and translational science (2024): e13829
Authors: Chernykh, Anastasia and Abrahams, Jodie L and Grant, Oliver C and Kambanis, Lucas and Sumer-Bayraktar, Zeynep and Ugonotti, Julian and Kawahara, Rebeca and Corcilius, Leo and Payne, Richard J and Woods, Robert J and Thaysen-Andersen, Morten
Journal: The Journal of biological chemistry (2024): 105519
Authors: Eleje, George Uchenna and Nwagha, Uchenna Ifeanyi and Ezebialu, Ifeanyichukwu Uzoma and Ugwu, Emmanuel Onyebuchi and Ekwuazi, Kingsley Emeka and Ikechebelu, Joseph Ifeanyichukwu and Ezugwu, Euzebus Chinonye and Eke, Ahizechukwu Chigoziem
Journal: Exploratory research and hypothesis in medicine (2024): 1-9
Authors: Hada, Yoshiko and Uchida, Haruhito A and Okamoto, Shugo and Otaka, Nozomu and Katayama, Katsuyoshi and Subramanian, Venkateswaran and Daugherty, Alan and Wada, Jun
Journal: American journal of hypertension (2024): 349-357